National Health Investors, Inc.
General ticker "NHI" information:
- Sector: Real Estate
- Industry: Health Care REITs
- Capitalization: $3.3B (TTM average)
National Health Investors, Inc. follows the US Stock Market performance with the rate: 32.3%.
Estimated limits based on current volatility of 0.9%: low 78.04$, high 79.45$
Factors to consider:
- Company pays dividends (quarterly): last record date 2025-09-30, amount 0.92$ (Y4.66%)
- Total employees count: 30 as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Pandemic risks, Climate change and natural disasters, Cybersecurity threats, Insurance risks, Labor/talent shortage/retention
- Price in estimated range
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [60.21$, 80.10$]
- 2025-12-31 to 2026-12-31 estimated range: [60.13$, 80.91$]
Financial Metrics affecting the NHI estimates:
- Negative: with PPE of 15.6 at the end of fiscal year the price was very high
- Positive: Operating profit margin, % of 54.85 > 18.64
- Positive: Inventory ratio change, % of 0.58 <= 0.84
- Positive: 6.82 < Operating cash flow per share per price, % of 6.85
- Positive: 5.52 < Industry operating cash flow per share per price (median), % of 7.52
- Positive: Interest expense per share per price, % of 1.85 <= 3.41
- Positive: 41.86 < Shareholder equity ratio, % of 52.27 <= 63.39
- Positive: -14.38 < Investing cash flow per share per price, % of -6.34
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 4.97
Short-term NHI quotes
Long-term NHI plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $278.19MM | $319.83MM | $335.18MM |
| Operating Expenses | $145.43MM | $141.04MM | $151.32MM |
| Operating Income | $132.77MM | $178.79MM | $183.86MM |
| Non-Operating Income | $-67.35MM | $-44.41MM | $-47.26MM |
| Interest Expense | $42.44MM | $55.51MM | $56.12MM |
| Income(Loss) | $65.41MM | $134.38MM | $136.59MM |
| Taxes | $-0.09MM | $0.00MM | $-0.04MM |
| Profit(Loss)* | $66.40MM | $135.65MM | $137.99MM |
| Stockholders Equity | $1,270.22MM | $1,253.95MM | $1,366.47MM |
| Assets | $2,507.42MM | $2,488.48MM | $2,614.37MM |
| Operating Cash Flow | $185.34MM | $184.45MM | $207.77MM |
| Capital expenditure | $4.63MM | $3.74MM | $4.07MM |
| Investing Cash Flow | $197.94MM | $-11.63MM | $-192.31MM |
| Financing Cash Flow | $-401.25MM | $-169.72MM | $-13.57MM |
| Earnings Per Share** | $1.48 | $3.13 | $3.15 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.